Novel tetrapeptides, tengupeptins A and B, produced by Lecanicillium aphanocladii FKI-9593 fungal strain

19 November 2024, Version 1
This content is a preprint and has not undergone peer review at the time of posting.

Abstract

The discovery of novel natural products through the exploration of distinct microorganisms is crucial for advancing drug discovery research. In this study, we focus on a unique environmental resource, microbial masses known as "Tengu-no-Mugimeshi." From the culture broth of Lecanicillium aphanocladii FKI-9593, isolated from Tengu-no-Mugimeshi collected at Mount Kurohime, Nagano Prefecture, Japan, we report the isolation of two novel tetrapeptides, tengupeptins A (1) and B (2), as well as the known compound oosporein. Structural analysis revealed that tengupeptins are composed of four amino acids: L-pyroglutamic acid for 1 (or L-glutamic acid for 2), (Z)-α,β-didehydro tryptophan (ΔZTrp), (Z)-α,β-didehydro-phenylalanine (ΔZPhe), and L-aspartic acid. Notably, dehydroamino acids containing an aromatic moiety conjugated with a double bond connected via two or more consecutive linkages are rare in natural products, and the ΔZTrp-ΔZPhe fragment represents the first example. The isolation of secondary metabolites from filamentous fungi inhabiting unique environments, such as Tengu-no-Mugimeshi, is anticipated to offer significant potential for future research.

Keywords

Tengu-no-Mugimeshi
Lecanicillium aphanocladii FKI-9593
natural product
tengupeptin
isolation

Supplementary materials

Title
Description
Actions
Title
Supporting Information of Tengupeptins
Description
Supporting Information of "Novel tetrapeptides, tengupeptins A and B, produced by Lecanicillium aphanocladii FKI-9593 fungal strain"
Actions

Comments

Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.